Rhumbline Advisers Travere Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 118,608 shares of TVTX stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,608
Previous 125,660 5.61%
Holding current value
$2.11 Million
Previous $1.03 Million 60.76%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$7.89 - $15.21 $55,640 - $107,260
-7,052 Reduced 5.61%
118,608 $1.66 Million
Q2 2024

Aug 01, 2024
BUY
$5.26 - $8.28 $98,072 - $154,380
18,645 Added 17.42%
125,660 $1.03 Million
Q1 2024

May 09, 2024
SELL
$7.18 - $9.82 $8,766 - $11,990
-1,221 Reduced 1.13%
107,015 $825,000
Q4 2023

Feb 08, 2024
SELL
$5.44 - $9.5 $26,237 - $45,818
-4,823 Reduced 4.27%
108,236 $973,000
Q3 2023

Nov 09, 2023
SELL
$7.64 - $17.25 $2,933 - $6,624
-384 Reduced 0.34%
113,059 $1.01 Million
Q2 2023

Aug 08, 2023
BUY
$15.3 - $22.61 $237,792 - $351,404
15,542 Added 15.88%
113,443 $1.74 Million
Q1 2023

May 11, 2023
BUY
$17.82 - $22.89 $4,722 - $6,065
265 Added 0.27%
97,901 $2.2 Million
Q4 2022

Feb 14, 2023
BUY
$18.47 - $26.14 $58,254 - $82,445
3,154 Added 3.34%
97,636 $2.05 Million
Q3 2022

Nov 10, 2022
BUY
$22.91 - $28.63 $158,674 - $198,291
6,926 Added 7.91%
94,482 $2.33 Million
Q2 2022

Aug 11, 2022
SELL
$20.94 - $30.01 $66,903 - $95,881
-3,195 Reduced 3.52%
87,556 $2.12 Million
Q1 2022

May 12, 2022
SELL
$23.61 - $30.6 $165,718 - $214,781
-7,019 Reduced 7.18%
90,751 $2.34 Million
Q4 2021

Feb 10, 2022
BUY
$24.34 - $31.17 $12,875 - $16,488
529 Added 0.54%
97,770 $3.04 Million
Q3 2021

Nov 12, 2021
BUY
$12.98 - $25.03 $39,056 - $75,315
3,009 Added 3.19%
97,241 $2.36 Million
Q2 2021

Aug 05, 2021
BUY
$14.11 - $26.4 $360,693 - $674,863
25,563 Added 37.23%
94,232 $1.38 Million
Q1 2021

May 06, 2021
SELL
$23.37 - $31.77 $56,298 - $76,533
-2,409 Reduced 3.39%
68,669 $1.72 Million
Q4 2020

Feb 10, 2021
BUY
$19.17 - $27.87 $1.36 Million - $1.98 Million
71,078 New
71,078 $1.94 Million

Others Institutions Holding TVTX

# of Institutions
193
Shares Held
84.6M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.14B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email